Carregant...
Change or Die: Targeting Adaptive Signaling to Kinase Inhibition in Cancer Cells
Small molecule kinase inhibitors have proven enormously successful at delivering impressive responses in patients with cancers as diverse as chronic myeloid-leukemia, melanoma, breast cancer and small cell lung cancer. Despite this, resistance is commonplace and most patients ultimately fail therapy...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4171341/ https://ncbi.nlm.nih.gov/pubmed/25107706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2014.07.031 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|